This page shows the latest Spiolto Respimat news and features for those working in and with pharma, biotech and healthcare.
fibrosis treatmentRespimat in COPD and Spiriva Respimat for asthma.
We are also looking at Spiriva Respimat in paediatric asthma patients because there is an unmet medical need there.”. ... Spiolto is positioned as offering greater benefits for patients and physicians than Spiriva and was approved in its first European
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...